Its continued use in laboratory investigations has contributed to a substantial body of research focused on peptide-mediated signalling mechanisms
Clinical Trials & Drug Development | AI & Digital Transformation in Clinical Research | Pharma & Biotech Strategy BREAKING NEWS - FDA approves first oral GLP-1 pill for obesity and weight management The oral GLP-1 era has officially begun
Known Side Effects and Risks Relevant to Women's Health Key risks for women include gastrointestinal effects, pancreatitis, gallbladder disease, and potential bone density loss, particularly relevant to perimenopausal and postmenopausal women
Tirzepatide mimics both the GLP-1 and GIP hormones in your body
Though the drug is approved for treating Type 2 diabetes and is often used to aid in weight loss users have reported an unintended side effect of taking the medication is a reduced craving to drink, suggesting it could potentially be used as a treatment in fighting alcoholism
Consistency over perfection is where results live